Jeevan Scientific Technology Achieves Zero Observations in USFDA Inspection of Bioanalytical Facility
Jeevan Scientific Technology Ltd has announced the successful completion of an inspection conducted by the United States Food and Drug Administration (USFDA) at its facility in Manikonda, Hyderabad. The company reported that the audit concluded with no observations, affirming its operational standards and regulatory compliance.The USFDA inspection focused on reviewing the BA/BE studies alongside the operations, systems, and procedures of Jeevan Scientific Technology Ltd. The review process began on July 20, 2026, and was concluded on July 24, 2026.
Following the comprehensive review, the inspectors formally closed the inspection with No Observations (Zero 483s).
The successful outcome signifies that the organization is compliant with all applicable regulations. The inspector noted that the entire JSTL team possesses the necessary training, knowledge, and experience related to International Regulatory requirements and Good practices. Furthermore, the company operates within an adequately designed infrastructure.
Stock Price Movement
As of 12:19, Jeevan Scientific Technology Ltd shares are edging higher, trading at ₹73.50 after a solid 2.18% climb. The company has maintained activity within an intraday range, having traded between the low of ₹72.00 and its current high of ₹73.50.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.